6TCS
Crystal structure of the omalizumab scFv
Summary for 6TCS
Entry DOI | 10.2210/pdb6tcs/pdb |
Descriptor | Omalizumab scFv, DI(HYDROXYETHYL)ETHER (3 entities in total) |
Functional Keywords | fab, antibody, immunoglobulin, immune system |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 1 |
Total formula weight | 29702.33 |
Authors | Mitropoulou, A.N.,Ceska, T.,Beavil, A.J.,Henry, A.J.,McDonnell, J.M.,Sutton, B.J.,Davies, A.M. (deposition date: 2019-11-06, release date: 2020-03-18, Last modification date: 2024-10-09) |
Primary citation | Mitropoulou, A.N.,Ceska, T.,Heads, J.T.,Beavil, A.J.,Henry, A.J.,McDonnell, J.M.,Sutton, B.J.,Davies, A.M. Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc complex crystallization. Acta Crystallogr.,Sect.F, 76:116-129, 2020 Cited by PubMed: 32133997DOI: 10.1107/S2053230X20001466 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.3 Å) |
Structure validation
Download full validation report